TABLE 3.
Haplotype | PP % (n = 448) | CS % (n = 464) | OR (CI 95%) | p Value |
---|---|---|---|---|
5C | 1 (5) | 2 (8) | 0.78 (0.20–2.74) | 0.66 |
5G | 20 (90) | 18 (84) | 1.33 (0.92–1.92) | 0.11 |
6C | 10 (44) | 6 (26) | 2.10 (1.22–3.69) | <0.01 |
6G ¶ | 45 (201) | 54 (250) | 1 | ‐ |
7C | 19 (84) | 16 (77) | 1.36 (0.93–1.98) | 0.10 |
7G | 5 (21) | 4 (17) | 1.54(0.75–3.19) | 0.20 |
8C | 0 (2) | 0 (1) | 2.47 (0.13–147) | 0.44 |
8G | 0 (1) | ‐ | ‐ | ‐ |
Abbreviations: PP, Plaque psoriasis patients; CS, control subjects; OR, odds ratio; CI, confidence interval.
Reference category. The p‐value was calculated by logistic regression comparison with the reference haplotype 6G.